Text messaging support for patients with diabetes or coronary artery disease (SupportMe): protocol for a pragmatic randomised controlled trial.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Corporate Authors:
      SupportMe investigators
    • Source:
      Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-6055 (Electronic) Linking ISSN: 20446055 NLM ISO Abbreviation: BMJ Open Subsets: MEDLINE
    • Publication Information:
      Original Publication: [London] : BMJ Publishing Group Ltd, 2011-
    • Subject Terms:
      Self-Management* ; Text Messaging*; Coronary Artery Disease/*therapy ; Diabetes Mellitus, Type 2/*therapy ; Telemedicine/*methods; Blood Pressure ; Cholesterol, LDL ; Exercise ; Glycated Hemoglobin ; Health Behavior ; Humans ; Life Style ; Medication Adherence ; Motivation ; Pragmatic Clinical Trials as Topic ; Quality of Life ; Reminder Systems ; Risk Factors ; Waist Circumference
    • Abstract:
      Introduction: Low-cost interventions providing self-management support are needed for people with coronary artery disease (CAD) and diabetes. Mobile phone text messaging provides a potential vehicle for this. The SupportMe Trial aims to assess the feasibility of embedding a text messaging programme into routine clinical practice and will determine if this improves cardiovascular risk factor and diabetes control among patients with CAD or type 2 diabetes.
      Methods and Analysis: SupportMe is a randomised controlled trial to be conducted within the framework of a health district-wide integrated care programme for people with CAD or type 2 diabetes mellitus. One thousand subjects will be recruited, with at least 500 in each group. Intervention subjects will receive four text messages a week for 6 months, which provide advice, motivation, information and support for disease management and healthy behaviour. The primary outcome is systolic blood pressure at 6 months. Secondary outcomes include body mass index, waist circumference, low-density lipoprotein cholesterol, physical activity levels, dietary intake, quality of life, mood and smoking cessation, and for subjects with diabetes, glycosylated haemoglobin and fasting serum glucose. A process and economic evaluation will also be conducted.
      Ethics and Dissemination: The study has been approved by the Western Sydney Local Health District Human Research Ethics Committee (AU RED HREC/16/WMEAD/331). Results will be disseminated via the scientific forums including peer-reviewed publications and presentations at national and international conferences.
      Trial Registration Number: ACTRN12616001689460.
      Competing Interests: Competing interests: None declared.
      (© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
    • References:
      BMJ. 2013 Oct 03;347:f5680. (PMID: 24092942)
      BMJ. 2010 Mar 23;340:c332. (PMID: 20332509)
      Worldviews Evid Based Nurs. 2014 Apr;11(2):81-8. (PMID: 24597522)
      Diabet Med. 2008 Aug;25(8):974-8. (PMID: 18959612)
      Diabetes Care. 2015 Aug;38(8):e112-3. (PMID: 26207059)
      Eur J Prev Cardiol. 2014 Apr;21(4):492-9. (PMID: 22605787)
      Diabetes Res Clin Pract. 2011 Dec;94(3):311-21. (PMID: 22079683)
      Ann Intern Med. 2005 Nov 1;143(9):659-72. (PMID: 16263889)
      BMJ. 2000 Aug 12;321(7258):405-12. (PMID: 10938048)
      JAMA. 2015 Sep 22-29;314(12):1255-63. (PMID: 26393848)
      N Engl J Med. 2008 Oct 9;359(15):1577-89. (PMID: 18784090)
      J Med Internet Res. 2016 Apr 19;18(4):e86. (PMID: 27095386)
      Diabetes Res Clin Pract. 2016 Jun;116:159-64. (PMID: 27321331)
      Circulation. 2010 Feb 16;121(6):750-8. (PMID: 20124123)
      Curr Cardiol Rep. 2017 Jan;19(1):4. (PMID: 28102482)
      Lancet. 1998 Sep 12;352(9131):837-53. (PMID: 9742976)
      JAMA Intern Med. 2016 Mar;176(3):340-9. (PMID: 26831740)
      Heart Asia. 2016 Sep 30;8(2):32-38. (PMID: 27752288)
      Heart Lung Circ. 2016 Aug;25(8):802-7. (PMID: 27262389)
      Aust Health Rev. 2019 Oct;43(5):565-571. (PMID: 30862349)
      J Hum Nutr Diet. 2015 Feb;28 Suppl 2:1-15. (PMID: 24480032)
      J Med Internet Res. 2013 Dec 19;15(12):e282. (PMID: 24356359)
      BMJ Open. 2012 Jan 19;2(1):e000606. (PMID: 22267690)
      Health Informatics J. 2016 Sep;22(3):451-69. (PMID: 25649783)
      Cochrane Database Syst Rev. 2016 Apr 10;4:CD006611. (PMID: 27060875)
      BMJ. 2018 May 17;361:k1959. (PMID: 29773539)
      Stroke. 2015 May;46(5):e121-2. (PMID: 25873596)
      Healthc Q. 2009;13 Spec No:16-23. (PMID: 20057244)
      Ann Intern Med. 2013 Feb 5;158(3):200-7. (PMID: 23295957)
      J Telemed Telecare. 2007;13(2):62-8. (PMID: 17359568)
      Stroke. 2005 Mar;36(3):635-8. (PMID: 15677576)
      Lancet. 2016 Oct 8;388(10053):1459-1544. (PMID: 27733281)
    • Contributed Indexing:
      Investigator: D Burgess; B Carr; NW Cheung; JG Cho; CK Chow; M Crampton; S Faruquie; C Ferry; R Haider; A Hayes; TM Hng; SM Shariful Islam; S Leeder; S Raadsma; J Redfern; C Rissel; A Thiagalingam
      Keywords: clinical trials; coronary heart disease; general diabetes; telemedicine
    • Molecular Sequence:
      ANZCTR ACTRN12616001689460
    • Accession Number:
      0 (Cholesterol, LDL)
      0 (Glycated Hemoglobin A)
    • Publication Date:
      Date Created: 20190622 Date Completed: 20200701 Latest Revision: 20240717
    • Publication Date:
      20240717
    • Accession Number:
      PMC6589039
    • Accession Number:
      10.1136/bmjopen-2018-025923
    • Accession Number:
      31221870